Search Orphan Drug Designations and Approvals
-
Generic Name: | Nitric oxide |
---|---|
Date Designated: | 09/27/2004 |
Orphan Designation: | To reduce the risk of chronic lung disease in premature neonates |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Mallinckrodt Pharmaceuticals Ireland Ltd. College Business & Technology Park Cruiserath Road Blanchardstown, Dublin D15 TX2V Ireland The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-